Renaissance Capital logo

ANNX News

US IPO Week Ahead: Foreign issuers dominate a 4 IPO week

RLX

Four IPOs are scheduled to raise $1.8 billion in the shortened holiday week, featuring a diverse group of foreign issuers.   China’s leading e-cigarette brand RLX Technology (RLX) plans to raise $1.0 billion at a $14.0 billion...read more

US IPO Weekly Recap: Software and SPACs shine in a 7 IPO week

JAMF

Seven IPOs and five SPACs entered public markets this past week, led by high-flying Jamf Holding (JAMF) and the largest SPAC ever Pershing Square Tontine Holdings (PSTHU). Four sizable biotechs all priced at the high end of...read more

Degenerative disease biotech Annexon prices further upsized IPO at $17, above the range

Annexon logo

Annexon, a Phase 1 biotech developing therapies for rare autoimmune diseases, raised $251 million by offering 14.8 million shares at $17, above the narrowed range of $15 to $16. The company offered 2.3 million more shares than anticipated. It originally...read more

Degenerative disease biotech Annexon increases proposed deal size by 29% ahead of $194 million IPO

Annexon logo

Annexon, a Phase 1 biotech developing therapies for rare autoimmune diseases, raised the proposed deal size for its upcoming IPO on Thursday. The South San Francisco, CA-based company now plans to raise $194 million by offering 12.5 million shares at a...read more